Dipeptidyl peptidase-4 inhibitor-induced autoimmune diseases: Current evidence

Dipeptidyl peptidase-4 inhibitors (DPP-4i) have an important place in the management of type 2 diabetes. The DPP-4 enzyme is ubiquitously distributed throughout the human body and has multiple substrates through which it regulates several important physiological functions. DPP-4 regulates several im...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Ayan, Sahoo, Jayaprakash, Narayanan, Niya, Merugu, Chandhana, Kamalanathan, Sadishkumar, Naik, Dukhabandhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472501/
https://www.ncbi.nlm.nih.gov/pubmed/34630898
http://dx.doi.org/10.4239/wjd.v12.i9.1426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472501/
https://www.ncbi.nlm.nih.gov/pubmed/34630898
http://dx.doi.org/10.4239/wjd.v12.i9.1426

Ejemplares similares